317 related articles for article (PubMed ID: 26424094)
1. Does Oral Beta-Blocker Therapy Improve Long-Term Survival in ST-Segment Elevation Myocardial Infarction With Preserved Systolic Function? A Meta-Analysis.
Misumida N; Harjai K; Kernis S; Kanei Y
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):280-5. PubMed ID: 26424094
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysis.
Maqsood MH; Alam M; Atar D; Birnbaum Y
J Cardiovasc Pharmacol; 2021 Jan; 77(1):87-93. PubMed ID: 33136764
[TBL] [Abstract][Full Text] [Related]
3. Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study.
Mohammad MA; Andell P; Koul S; Desta L; Jernberg T; Omerovic E; Spaak J; Fröbert O; Jensen J; Engstrøm T; Hofman-Bang C; Persson H; Erlinge D
EuroIntervention; 2017 Jun; 13(2):e210-e218. PubMed ID: 28242589
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of β-blocker in ST-segment elevation myocardial infarction in patients with preserved left ventricular systolic function: a propensity analysis.
Konishi H; Miyauchi K; Kasai T; Tsuboi S; Ogita M; Naito R; Nishizaki Y; Okai I; Tamura H; Okazaki S; Isoda K; Daida H
Heart Vessels; 2016 Apr; 31(4):441-8. PubMed ID: 25573259
[TBL] [Abstract][Full Text] [Related]
5. Direct Admission Versus Interhospital Transfer for Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction.
Kawecki D; Gierlotka M; Morawiec B; Hawranek M; Tajstra M; Skrzypek M; Wojakowski W; Poloński L; Nowalany-Kozielska E; Gąsior M
JACC Cardiovasc Interv; 2017 Mar; 10(5):438-447. PubMed ID: 28216215
[TBL] [Abstract][Full Text] [Related]
6. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Kim JH; Ahn YK; Jeong MH; Choi DJ; Park JS; Kim YJ; Park HS; Han KR; Rha SW; Gwon HC
JACC Cardiovasc Interv; 2014 Jun; 7(6):592-601. PubMed ID: 24947717
[TBL] [Abstract][Full Text] [Related]
7. Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention.
Ozasa N; Kimura T; Morimoto T; Hou H; Tamura T; Shizuta S; Nakagawa Y; Furukawa Y; Hayashi Y; Nakao K; Matsuzaki M; Nobuyoshi M; Mitsudo K;
Am J Cardiol; 2010 Nov; 106(9):1225-33. PubMed ID: 21029817
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis.
Dahl Aarvik M; Sandven I; Dondo TB; Gale CP; Ruddox V; Munkhaugen J; Atar D; Otterstad JE
Eur Heart J Cardiovasc Pharmacother; 2019 Jan; 5(1):12-20. PubMed ID: 30192930
[TBL] [Abstract][Full Text] [Related]
9. Clinical impacts of inhibition of renin-angiotensin system in patients with acute ST-segment elevation myocardial infarction who underwent successful late percutaneous coronary intervention.
Park H; Kim HK; Jeong MH; Cho JY; Lee KH; Sim DS; Yoon NS; Yoon HJ; Hong YJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kim YJ; Cho MC; Kim CJ;
J Cardiol; 2017 Jan; 69(1):216-221. PubMed ID: 27141820
[TBL] [Abstract][Full Text] [Related]
10. Combined assessment of left ventricular end-diastolic pressure and ejection fraction by left ventriculography predicts long-term outcomes of patients with ST-segment elevation myocardial infarction.
Saito D; Nakanishi R; Watanabe I; Yabe T; Okubo R; Amano H; Toda M; Ikeda T
Heart Vessels; 2018 May; 33(5):453-461. PubMed ID: 29143103
[TBL] [Abstract][Full Text] [Related]
11. Intravenous beta-blockers in ST-segment elevation myocardial infarction: A systematic review and meta-analysis.
Sterling LH; Filion KB; Atallah R; Reynier P; Eisenberg MJ
Int J Cardiol; 2017 Feb; 228():295-302. PubMed ID: 27866018
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with aspiration thrombectomy Vs. Conventional percutaneous coronary intervention during ST-segment elevation myocardial infarction.
Dominguez AC; Bittl JA; El-Hayek G; Contreras E; Tamis-Holland JE
Catheter Cardiovasc Interv; 2016 Jun; 87(7):1203-10. PubMed ID: 26699698
[TBL] [Abstract][Full Text] [Related]
13. Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Watanabe H; Ozasa N; Morimoto T; Shiomi H; Bingyuan B; Suwa S; Nakagawa Y; Izumi C; Kadota K; Ikeguchi S; Hibi K; Furukawa Y; Kaji S; Suzuki T; Akao M; Inada T; Hayashi Y; Nanasato M; Okutsu M; Kametani R; Sone T; Sugimura Y; Kawai K; Abe M; Kaneko H; Nakamura S; Kimura T;
PLoS One; 2018; 13(8):e0199347. PubMed ID: 30153268
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic warfarin post anterior ST-elevation myocardial infarction: A systematic review and meta-analysis.
Moulson N; LaHaye SA; Bertrand OF; MacHaalany J
Cardiovasc Revasc Med; 2017 Dec; 18(8):559-564. PubMed ID: 28501493
[TBL] [Abstract][Full Text] [Related]
15. The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics.
Kristensen AMD; Munkhaugen J; Halvorsen S; Olsen MH; Bakken A; Sehested TSG; Ruddox V; Lange T; Fagerland MW; Torp-Pedersen C; Prescott E; Atar D
Eur Heart J Cardiovasc Pharmacother; 2024 May; 10(3):175-183. PubMed ID: 38017624
[TBL] [Abstract][Full Text] [Related]
16. Effect of Guideline-Based Therapy on Left Ventricular Systolic Function Recovery After ST-Segment Elevation Myocardial Infarction.
Abou R; Leung M; Goedemans L; Hoogslag GE; Schalij MJ; Marsan NA; Bax JJ; Delgado V
Am J Cardiol; 2018 Nov; 122(10):1591-1597. PubMed ID: 30213383
[TBL] [Abstract][Full Text] [Related]
17. Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.
Hioki H; Motoki H; Izawa A; Kashima Y; Miura T; Ebisawa S; Tomita T; Miyashita Y; Koyama J; Ikeda U
Heart Vessels; 2016 May; 31(5):687-93. PubMed ID: 25863805
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: prospective cohort study.
Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Jeong MH; Choi DJ; Park JS; Park HS; Gwon HC
BMJ; 2014 Nov; 349():g6650. PubMed ID: 25398372
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and Prognostic Impact of Prophylactic Oral Anticoagulation in Anterior ST-Segment Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction.
Shavadia JS; Youngson E; Bainey KR; Bakal J; Welsh RC
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673899
[TBL] [Abstract][Full Text] [Related]
20. High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
Du Y; Zhao Y; Zhu Y; Hu C; Zhang J; Ji Q; Liu W; Han H; Yang L; Zhang D; Tong S; Wang Z; Guo Y; Liu X; Zhou Y
J Atheroscler Thromb; 2019 Oct; 26(10):868-878. PubMed ID: 30773518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
